NASDAQ$NUVL

Nuvalent Inc · Q1 2025 earnings

Q1 2025 earnings · · Before market open · Investor relations

Briefing

Nuvalent reported Q1 2025 a net loss of $84.6M, diluted EPS of $-1.45.

For Q1 2025, Nuvalent reported net loss was $84.6M, diluted EPS was $-1.45. Management discusses segment trends, liquidity, and outlook in the quarterly filing.

  • Net loss $84.6M.
  • Diluted EPS $-1.45.
  • MD&A highlights operating priorities, liquidity, and sector risks.

Headline financials

Total Revenue

$0.00

Previous: $0.00
EPS (adj)

-$1.45

Previous: -$0.69-110.1%
Research and development expenses

$74.4M

Previous: $38.6M+92.6%
General and administrative expenses

$20.4M

Previous: $14M+46.2%
Interest income and other income (expense), net

$11.8M

Previous: $8.49M+39.2%
Stock-based compensation expense

$20.4M

Previous: $13.9M+47.1%
Net Income

-$84.6M

Previous: -$44.5M-90.1%
Operating Income

-$94.8M

Previous: -$52.6M-80.3%

Revenue & EPS history

Nuvalent · Revenue · Quarterly

$0

Q1 2025

Forward guidance

Outlook emphasizes clinical milestones, liquidity runway, and cost discipline.

Tailwinds

  • Pipeline readouts and partnership economics.
  • Cash balance supports near-term development plans.

Headwinds

  • Operating losses and trial risk until commercialization.
  • Financing markets and competition affect funding costs.

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 17 quarterly earnings reports · overlaid with Q1 2025

Historical avgQ1 2025

-0.0%

Avg return

Earnings day

-0.8%

Avg return

5 days after

-7.7%

Avg return

30 days after

38%

8 / 21 earnings

Positive

+14.6%

Q4 2021

Best reaction

-5.0%

Q3 2025

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q4 2025-0.5%-4.1%-7.5%
Q3 2025-5.0%-11.6%+6.2%
Q1 2025+3.2%+3.7%+10.2%
Q4 2024-2.8%-7.0%-5.2%
Q3 2024-4.3%-8.0%-8.0%
Q1 2024-3.1%+0.7%+17.2%
Q4 2023-1.4%+0.6%-13.3%
Q3 2023+3.7%+5.0%+38.8%
Q2 2023-1.1%-3.1%+9.2%
Q1 2023-2.5%-1.1%+3.5%
Q4 2022+8.3%+4.7%+0.9%
Q3 2022+1.0%+2.9%-2.1%
Q2 2022+4.5%+9.3%+13.1%
Q1 2022-0.7%+7.3%+16.1%
Q4 2021+14.6%+20.2%-8.1%
Q3 2020+1.3%-14.7%-2.4%
Q3 2021+1.3%-10.4%-20.1%
Q2 2020-4.3%-2.9%-52.6%
Q1 2021-4.3%-2.9%-52.6%
Q2 2021-4.3%-2.9%-52.6%
Q4 2020-4.3%-2.9%-52.6%
Q1 2020

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro